Cleveland Alcohol Center
Director: Laura E. Nagy, PhD
The Cleveland Alcohol Center is an NIAAA/NIH funded P20 Developmental/Exploratory Center that takes advantage of the many strengths of the world-class research community at the Cleveland Clinic and Case Western Reserve University to address the important public health issue of alcoholic liver disease (ALD). The CAC is an interdisciplinary team of investigators expert in measuring in vivo markers of biochemical and molecular stress, as well as assessing the cellular/organismal responses to that stress. Basic scientists and clinical investigators will interact not only to translate basic science advances to clinical investigations (bench to bedside), but also to translate the clinical experience into refining and advancing the approach of basic research studies (bedside to bench) on the mechanisms for ALD.
Our long-term goal is to promote interdisciplinary investigations into understanding the molecular targets of ethanol-induced damage, as well as the cellular and systemic responses to damage, in order to rationally design and test therapeutic interventions to either slow and/or reverse the progression of ALD.
January 29, 2016: Cleveland Alcohol Center Meeting
8:00 AM, Room NE4-218, Lerner Research Institute, Cleveland Clinic
Presenter: Gail Cresci, PhD, Associate Staff, Pathobiology, Cleveland Clinic
Title: “Tributyrin and protecting the intestine from ethanol-induced injury”